Award
Delivery Order #SPE2DR26FJFU4
DMS Pharmaceutical Group Awarded Delivery Order for Xolair Auto-injectors
Buyer
Defense Logistics Agency
Award Amount
$3,494.88
Ceiling
$3,494.88
Awarded
March 04, 2026
Period of Performance
Mar 04, 2026 – Mar 25, 2026
Identifier
SPE2DR26FJFU4
NAICS
424210
This delivery order contract was recently awarded to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution and healthcare services. The contract involves the procurement of Xolair 150 MG/ML auto-injectors, essential medication used in treating specific allergic conditions. The award represents a continuation under a long-term indefinite delivery vehicle (IDV) contract, emphasizing the sustained healthcare support provided by DMS Pharmaceutical Group to federal agencies. The scope of work includes delivering the specified pharmaceutical products within a short-term performance period, ensuring timely availability of this critical treatment. The contract was awarded competitively through the existing IDV framework, promoting efficient procurement practices. Key milestones include the contract's start and end dates within March 2026. This delivery order demonstrates the ongoing commitment to maintaining consistent access to vital healthcare products for the public sector.
Description
4571079121!XOLAIR 150 MG/ML AUTOINJECTORML